A Study of RG-012 in Subjects With Alport Syndrome
Condition: Alport Syndrome Intervention: Drug: RG012 Sponsor: Regulus Therapeutics Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alport Syndrome | Study